Histological observations and the process of ultrasound contrast agent enhancement of tissue plasminogen activator thrombolysis with ultrasound exposureKONDO, I; MIZUSHIGE, K; UEDA, T et al.Japanese Circulation Journal. 1999, Vol 63, Num 6, pp 478-484, issn 0047-1828Article

Amyloid β peptides stimulate tissue-type plasminogen activator but not recombinant prourokinaseWNENDT, S; WETZELS, I; GÜNZLER, W. A et al.Thrombosis research. 1997, Vol 85, Num 3, pp 217-224, issn 0049-3848Article

Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminansAIUTO, L. T; BARONE, S. R; COHEN, P. S et al.Critical care medicine. 1997, Vol 25, Num 6, pp 1079-1082, issn 0090-3493Article

The production of improved tissue-type plasminogen activator in Escherichia coliMATTES, Ralf.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 4, pp 325-335, issn 0094-6176Article

Bioactivity of cryopreserved alteplase solutionsCALIS, K. A; CULLINANE, A. M; HORNE, M. K et al.American journal of health-system pharmacy. 1999, Vol 56, Num 20, pp 2056-2057, issn 1079-2082Article

Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA)TRUSEN, B; RIES, M; ZENKER, M et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 6, pp 599-604, issn 0094-6176Article

6 Ans après GUSTO-1… Permeabilité artérielle, fonction ventriculaire et mortalité = 6 years after GUSTO-1... Arterial permeability, ventricular fonction and mortalityBASSAND, J.-P.Etudes & évaluation cardio-vasculaires. 1998, Vol 5, Num 8, pp 305-313, issn 1251-3571Article

A fresh look at the molecular pharmacology of plasminogen activators : From theory to test tube to clinical outcomesSMALLING, R. W.American journal of health-system pharmacy. 1997, Vol 54, Num 22, pp S17-S22, issn 1079-2082, SUP1Conference Paper

Use of tissue plasminogen activator in obstructed peritoneal dialysis cathetersHUTCHINSON, Pamela J; CHAND, Deepa H.Dialysis & transplantation. 2001, Vol 30, Num 2, pp 104-108, issn 0090-2934, 3 p.Article

Irrigation with tissue-type plasminogen activator removes obstruction after dacryocystorhinostomySAIKA, S; OKADA, Y; TANAKA, S.-I et al.Annals of ophthalmology. Glaucoma. 1998, Vol 30, Num 5, pp 276-277, issn 1079-4794Article

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsEMBERSON, Jonathan; LEES, Kennedy R; GROTTA, James et al.Lancet (British edition). 2014, Vol 384, Num 9958, pp 1929-1935, issn 0140-6736, 7 p.Article

Safety of subcutaneous enoxaparin as ancillary therapy in STEMI patients receiving fibrinolysisROTT, David; LEIBOWITZ, David.International journal of cardiology. 2013, Vol 168, Num 2, issn 0167-5273, p. 1582Article

Clinical Controversies in Thrombolytic Therapy for the Management of Acute Pulmonary EmbolismDALEY, Mitchell J; LAT, Ishaq.Pharmacotherapy. 2012, Vol 32, Num 2, pp 158-172, issn 0277-0008, 15 p.Article

Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trialZINKSTOK, Sanne M; ROOS, Yvo B.Lancet (British edition). 2012, Vol 380, Num 9843, pp 731-737, issn 0140-6736, 7 p.Article

Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy: A Validation Study of Home Time as an Outcome MeasureMISHRA, Nishant K; SHUAIB, Ashfaq; LYDEN, Patrick et al.Stroke (1970). 2011, Vol 42, Num 4, pp 1046-1050, issn 0039-2499, 5 p.Article

EFFECTIVENESS OF THROMBOLYSIS WITH INTRAVENOUS ALTEPLASE FOR ACUTE ISCHEMIC STROKE IN OLDER ADULTSDIRKS, Maaike; KOUDSTAAL, Peter J; DIPPEL, Diederik W. J et al.Journal of the American Geriatrics Society. 2011, Vol 59, Num 11, pp 2169-2171, issn 0002-8614, 3 p.Article

Desmoteplase in acute massive pulmonary thromboembolismTEBBE, Ulrich; BRAMLAGE, Peter; GRAF, Andreas et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 557-562, issn 0340-6245, 6 p.Article

Pilot Study of Alteplase (Tissue Plasminogen Activator) for Treatment of Urinary Clot Retention in an In Vitro ModelRITCH, Chad R; ORDONEZ, Maria A; OKHUNOV, Zhamshid et al.Journal of endourology. 2009, Vol 23, Num 8, pp 1353-1357, issn 0892-7790, 5 p.Article

Infarctus cerebral : « time is brain »! : Ischémie cérébrale = Acute ischemic stroke : time is brain !LARRUE, Vincent.La Revue du praticien (Paris). 2006, Vol 56, Num 13, pp 1418-1423, issn 0035-2640, 6 p.Article

Coronary angiojet catheterization for the management of dural venous sinus thrombosis : Technical noteAGNER, Celso; DESHAIES, Eric M; BERNARDINI, Gary L et al.Journal of neurosurgery. 2005, Vol 103, Num 2, pp 368-371, issn 0022-3085, 4 p.Article

Thrombolysis in acute ischaemic stroke : A guide to patient selectionLINDLEY, Richard I.CNS drugs. 2005, Vol 19, Num 6, pp 539-551, issn 1172-7047, 13 p.Article

Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarctionBINBREK, Azan S; RAO, Nayan S; NEIMANE, Dagnija et al.The American journal of cardiology. 2004, Vol 93, Num 12, pp 1465-1468, issn 0002-9149, 4 p.Article

Altéplase (Actilyse®). Nouvelle indication dans l'AVC ischémique : Une évaluation insuffisante = Alteplase (Actilyse®). New indication in ischemic stroke : An insufficient evaluationLa Revue Prescrire. 2004, Vol 24, Num 248, pp 176-180, issn 0247-7750, 5 p.Article

Comparative fibrinolytic activity of front-loaded alteplase and the single-bolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarctionAL-SHWAFI, Kamal A; DE MEESTER, Antoine; PIRENNE, Bruno et al.The American heart journal. 2003, Vol 145, Num 2, pp 217-225, issn 0002-8703, 9 p.Article

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: Implications for clinical trialsLAMBERT, Vincent; MUNAUT, Carine; CARMELIET, Peter et al.Investigative ophthalmology & visual science. 2003, Vol 44, Num 6, pp 2791-2797, issn 0146-0404, 7 p.Article